Cancer Immunology Research (CIR) is a scholarly journal dedicated to publishing research in the field of Immunology and Microbiology. American Association for Cancer Research is the publisher of this esteemed journal. The P-ISSN assigned to Cancer Immunology Research is 2326-6066 and its abbreviated form is Cancer Immunol Res.
Cancer Immunology Research publishes outstanding original articles reporting major advances that span the discipline of cancer immunology, from basic investigations of host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and in-depth analysis of late-stage clinical trials. The journal also publishes reviews and opinion pieces of broad significance across the spectrum of cancer immunology research. As the premier resource for disseminating knowledge of immunology to the cancer research community, the journal catalyzes cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.
Specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and immunologically insightful clinical investigations.
|Journal title||Cancer Immunology Research (CIR)|
|Abbreviation||Cancer Immunol Res|
|Publisher Name||American Association for Cancer Research|
|Editor-in-chief||Robert D. Schreiber, Philip D. Greenberg|
|Subject Category||Immunology and Microbiology|
Cancer Immunology Research Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Cancer Immunology Research Journal is Cancer Immunol Res.
The Ranking of Cancer Immunology Research in 2023 is 461. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Impact Factor of Cancer Immunology Research in 2023 is 10.1. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The SCImago of Cancer Immunology Research in 2023 is 3.552. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The H-Index of Cancer Immunology Research in 2023 is 116. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Quartile of Cancer Immunology Research is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Cancer Immunology Research is indexed in (Indexing details)
|PubMed||Scopus||Web of Science||UGC||Embase||DOAJ|
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
|Abbreviation||Cancer Immunol Res|
The Editor-in-chief of Cancer Immunology Research is Robert D. Schreiber, Philip D. Greenberg
Cancer Immunology Research Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of Cancer Immunology Research is $2400
Cancer Immunology Research Call for paper : Cancer Immunology Research invites original research contributions for consideration of publication in Cancer Immunology Research journal.
Journal seeking submissions in the broad areas of Immunology and Microbiology that align with journal's focus on Immunology and Microbiology.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Cancer Immunology Research involves the following steps:
No, the Cancer Immunology Research journal is not indexed in PubMed.
Yes, the Cancer Immunology Research journal is indexed in Scopus.
Yes, the Cancer Immunology Research journal is indexed in UGC.
No, the Cancer Immunology Research journal is not indexed in Index copernicus.
No, Cancer Immunology Research journal is not a predatory journal.
The Impact Factor of the Cancer Immunology Research is 10.1.
The Ranking of the Cancer Immunology Research is 461.
Yes the Cancer Immunology Research (CIR) journal is a peer-reviewed journal.
Yes the Cancer Immunology Research journal is a peer-reviewed journal and good to publish your paper.
Yes, Cancer Immunology Research is a open access (Hybrid) journal.